The agency also granted traditional approval to later-line nivolumab indications for certain adults with the disease.
The FDA has approved the combination of nivolumab plus chemotherapy as first-line treatment for certain patients with stage III or IV classical Hodgkin lymphoma.The approval, for individuals aged 12 ...
FDA approval extends nivolumab into first-line stage III/IV cHL in adults and pediatrics, following priority review of the supplemental application for nivolumab plus AVD. SWOG S1826 showed superior ...
Frontline nivolumab plus AVD reduced risk of progression or death by 58% versus brentuximab vedotin plus AVD (PFS HR, 0.42) in advanced-stage classical Hodgkin lymphoma. CA209-8UT randomized 994 ...
Taking GLP-1 drugs for diabetes has been shown to lower the risk of ​adverse heart events, but a new analysis found that going off the medication – even for a few months – may increase the ‌odds of ...
Research finds that even short gaps in treatment with a GLP-1 can drive up risks of heart attack, stroke and death in ...
A major study links Wegovy to a rare form of sudden vision loss, and finds men may face three times the risk of women.
Doctors in India are increasingly exploring “dose optimisation” to make expensive treatments more affordable while also reducing side-effects, and new findings from Tata Memorial Hospital highlight ...
A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...
Eating raw beets is generally safe when eaten in moderation, although they may cause gas and bloating in some people, or turn your urine and stool a pinkish or reddish color. Other, more serious ...
aDepartment of Medical Oncology, Christian Medical College Vellore, India bDepartment of General Pathology, Christian Medical College Vellore, India cDepartment of Radiology, Christian Medical College ...
Emotional concerns due to kidney cancer (KC) and disparities in patient support across North America (NA): Results from the International Kidney Cancer Coalition (IKCC) global patient survey (GPS).